Form 4 for CL Colgate-Palmolive
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001225208-24-005537 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-03 | 2024-05-01 | CL | BILBREY JOHN P | Dir | S - Sale+OE | $91.59 | -6,329 | 30.2K | -17% | -$579.7K |
| D | 2024-05-03 | 2024-05-01 | CL | BILBREY JOHN P | Dir | M - OptEx | $62.04 | +6,329 | 36.6K | +21% | +$392.7K |
| D | 2024-05-03 | 2024-05-01 | CL | BILBREY JOHN P | Dir | M - OptEx | $0.00 | -6,329 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | S | D | 6,329 | $91.59 | 30,236 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-01 | M | A | 6,329 | $62.04 | 36,565 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 6,329 | $0.00 | 0 | D | $62.04 · — to 2024-05-14 | 6,329 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date. |